SCHEMBL4253743

SCHEMBL4253743

Oc1ccc2c3c(ccc2c1)OC(c1ccccc1)(c1ccccc1)C=C3

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.37
HSP90AA1 P07900 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36
PTPN1 P18031 2/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CYP1A2 P05177 1/20 0.35
ESR1 P03372 3/20 0.34
ESR2 Q92731 3/20 0.34
CDK4 P11802 1/20 0.34
CCND1 P24385 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13779564 0.84 PTPN1 (0.40) APPHSP90AA1KDM4EMEN1NPC1
SCHEMBL4251941 0.84 PTPN1 (0.40) APPHSP90AA1KDM4EMEN1NPC1
SCHEMBL7263829 0.84 SIRT2 (0.38) KDM4EMEN1NPC1ALDH1A1LMNA
SCHEMBL364008 0.83 KDM4E (0.34) KDM4EMEN1NPC1ALDH1A1LMNA
SCHEMBL361847 0.83 KDM4E (0.50) APPKDM4EMEN1NPC1ALDH1A1
SCHEMBL7971753 0.81 HTT (0.36) KDM4EMEN1NPC1ALDH1A1LMNA
SCHEMBL5264237 0.81 CYP1A2 (0.41) KDM4EMEN1NPC1ALDH1A1LMNA
SCHEMBL20848052 0.80 KDM4E (0.39) HSP90AA1KDM4EMEN1NPC1ALDH1A1
SCHEMBL7128812 0.79 MAPT (0.40) KDM4EMEN1NPC1ALDH1A1LMNA
SCHEMBL361912 0.79 LCK (0.45) KDM4EALDH1A1GAAMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090170926-A1 Antiviral agents MONASH UNIVERISTY (AU) 2009-07-02 US disclosed
US-20090170926-A1 Antiviral agents MONASH UNIVERISTY (AU) 2009-07-02 US disclosed
US-20090170926-A1 Antiviral agents MONASH UNIVERISTY (AU) 2009-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170926-A1 Antiviral agents SLC10A1, HAVCR2, ZC3HAV1 APP 4615/4885HSP90AA1 1442/4885KDM4E 3234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.